Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.
Here’s Why Warren Buffett-backed BYD Stock Is A Better Electric-vehicle Bet Than Tesla
BYD, a Chinese EV maker, could surpass Tesla in BEV sales, despite their market valuation differences.